Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 11.03.2024 1 Antimicrob Agents Chemother 1 Arch Dis Child 1 BMJ 1 Cell 4 HIV Med 1 J Am Acad Dermatol 2 J Infect Dis 1 J Med Virol 3 JAMA 1 Nat Med 1 Pediatr Infect Dis J 5 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Science 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. JOGIRAJU V, Weber E, Hindman J, West S, et al
   Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment.
   Antimicrob Agents Chemother. 2024 Mar 8:e0134423. doi: 10.1128/aac.01344.
   PubMed         Abstract available
   
   

   
   Arch Dis Child

2. SOUSA NUNES B, Marques-Matos C, Conceicao C, Silva TM, et al
   Progressive multifocal leukoencephalopathy in children with HIV: still a challenge.
   Arch Dis Child. 2024 Mar 4:archdischild-2023-326609.
   PubMed        
   
   

   
   BMJ

3. MAHASE E
   HIV: WHO reports "worrying" increase in resistance to key antiretroviral treatment.
   BMJ. 2024;384:q573.
   PubMed        
   
   

   
   Cell

4. WANG Q, Clark KM, Tiwari R, Raju N, et al
   The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression.
   Cell. 2024;187:1223-1237.
   PubMed         Abstract available
   
   

   
   HIV Med

5. NOE S, Ivanova A, Johnsson-Oldenbuttel C, Schafer G, et al
   Immunological alterations with GLP-1 agonists in people living with HIV.
   HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13631.
   PubMed        
   
   
6. FURSA O, Bannister W, Neesgaard B, Podlekareva D, et al
   SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
   HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13620.
   PubMed         Abstract available
   
   
7. PALICH R, Rodger AJ, Nicholls EJ, Wright T, et al
   Experiences with health care services and HIV testing after sexual assault in cisgender gay, bisexual and other men who have sex with men and transgender people.
   HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13629.
   PubMed         Abstract available
   
   
8. TAHA AM, Elrosasy A, Mahmoud AM, Saed SAA, et al
   The effect of HIV and mpox co-infection on clinical outcomes: Systematic review and meta-analysis.
   HIV Med. 2024 Mar 5. doi: 10.1111/hiv.13622.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

9. SOOD S, Geng R, Heung M, Yeung J, et al
   Use of Biologic Treatment in Psoriasis Patients with HIV: A Systematic Review.
   J Am Acad Dermatol. 2024 Mar 5:S0190-9622(24)00442.
   PubMed        
   
   

   
   J Infect Dis

10. COLON W, Oriol Mathieu V, Hural J, Hattingh L, et al
    HIV Diagnostics and Vaccines: It Takes Two to Tango.
    J Infect Dis. 2024 Mar 7:jiae113. doi: 10.1093.
    PubMed         Abstract available
    
    
11. WILCOX CS, Herbert C, Wang C, Ma Y, et al
    Signals From Inflamed Perivascular Adipose Tissue Contribute to Small Vessel Dysfunction in Women Living With the Human Immunodeficiency Virus.
    J Infect Dis. 2024 Mar 1:jiae094. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

12. XIE M, Wang Z, Zhao F, Li Y, et al
    Structure-based design of diarylpyrimidines and triarylpyrimidines as potent HIV-1 NNRTIs with improved metabolic stability and drug resistance profiles.
    J Med Virol. 2024;96:e29502.
    PubMed         Abstract available
    
    

    
    JAMA

13. PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
    Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial.
    JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
    PubMed         Abstract available
    
    
14. AMICO KR
    A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
    PubMed        
    
    
15. HARRIS E
    Long-Acting HIV Treatment Superior to Daily Oral Drugs.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
    PubMed        
    
    

    
    Nat Med

16. NARASIMHAN M, Hargreaves JR, Logie CH, Abdool-Karim Q, et al
    Self-care interventions for women's health and well-being.
    Nat Med. 2024 Mar 7. doi: 10.1038/s41591-024-02844.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

17. NYAKATO P, Boulle A, Wood R, Eley B, et al
    Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records.
    Pediatr Infect Dis J. 2024 Feb 21. doi: 10.1097/INF.0000000000004281.
    PubMed         Abstract available
    
    

    
    PLoS One

18. MUTAMBA BB, Rukundo GZ, Sembajjwe W, Nakasujja N, et al
    A 'hidden problem': Nature, prevalence and factors associated with sexual dysfunction in persons living with HIV/AIDS in Uganda.
    PLoS One. 2024;19:e0295224.
    PubMed         Abstract available
    
    
19. OGELLO VA, Rono BK, Ngure K, Sedah E, et al
    Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study.
    PLoS One. 2024;19:e0299168.
    PubMed         Abstract available
    
    
20. SACKEYA E, Beru MM, Angmortey RN, Opoku DA, et al
    Survival trends among people living with human immunodeficiency virus on antiretroviral treatment in two rural districts in Ghana.
    PLoS One. 2024;19:e0290810.
    PubMed         Abstract available
    
    
21. BESCHORNER N, Kunzle P, Voges M, Hauber I, et al
    Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1.
    PLoS One. 2024;19:e0298542.
    PubMed         Abstract available
    
    
22. ROUCOUX G, Thonon F, Zucman D, Rey D, et al
    Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
    PLoS One. 2024;19:e0295223.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

23. BENNETT SJ, Yalcin D, Privatt SR, Ngalamika O, et al
    Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.
    PLoS Pathog. 2024;20:e1012023.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. OBRIEN SJ
    Legacy of a magic gene-CCR5-?32: From discovery to clinical benefit in a generation.
    Proc Natl Acad Sci U S A. 2024;121:e2321907121.
    PubMed         Abstract available
    
    

    
    Science

25. COHEN J
    Skin side effects stymie advance of HIV vaccine.
    Science. 2024;383:1044.
    PubMed         Abstract available
    
    

    
    Vaccine

26. BEAVIS AC, Dienger-Stambaugh K, Briggs K, Chen Z, et al
    A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice.
    Vaccine. 2024 Mar 4:S0264-410X(24)00227-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
27. MENG L, Harris L, Shaw L, Lymon H, et al
    Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged >/= 12 years, United States, August 2021-October 2
    Vaccine. 2024 Mar 6:S0264-410X(24)00271-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.